The DFS curve for women with tumours which were classified as having 'high levels' of SOCS3 transcript was found to differ significantly from that of their 'low level' counterparts, showing a significant benefit in predicting better DFS (p = 0.024). This evidence concerns the gene SOCS3 and neoplasm.